Büşra Gürpınar Tosun

Efficacy of the Novel Degludec/Aspart Insulin Co-formulation in Children and Adolescents with Type 1 Diabetes: A Real-life Experience with One Year of IDegAsp Therapy in Poorly Controlled and Non-compliant Patients

A. Bereket, S. Turan, T. Güran, 2021, Journal of clinical research in pediatric endocrinology.